Krause Ulrike, Bertrand Luc, Hue Louis
Hormone and Metabolic Research Unit, Christian de Duve International Institute of Cellular and Molecular Pathology and University of Louvain Medical School, Brussels, Belgium.
Eur J Biochem. 2002 Aug;269(15):3751-9. doi: 10.1046/j.1432-1033.2002.03074.x.
Certain amino acids, like glutamine and leucine, induce an anabolic response in liver. They activate p70 ribosomal protein S6 kinase (p70S6K) and acetyl-CoA carboxylase (ACC) involved in protein and fatty acids synthesis, respectively. In contrast, the AMP-activated protein kinase (AMPK), which senses the energy state of the cell and becomes activated under metabolic stress, inactivates by phosphorylation key enzymes in biosynthetic pathways thereby conserving ATP. In this paper, we studied the effect of AMPK activation and of protein phosphatase inhibitors, on the amino-acid-induced activation of p70S6K and ACC in hepatocytes in suspension. AMPK was activated under anoxic conditions or by incubation with 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAr) or oligomycin, an inhibitor of mitochondrial oxidative phosphorylation. Incubation of hepatocytes with amino acids activated p70S6K via multiple phosphorylation. It also activated ACC by a phosphatase-dependent mechanism but did not modify AMPK activation. Conversely, the amino-acid-induced activation of both ACC and p70S6K was blocked or reversed when AMPK was activated. This AMPK activation increased Ser79 phosphorylation in ACC but decreased Thr389 phosphorylation in p70S6K. Protein phosphatase inhibitors prevented p70S6K activation when added prior to the incubation with amino acids, whereas they enhanced p70S6K activation when added after the preincubation with amino acids. It is concluded that (a) AMPK blocks amino-acid-induced activation of ACC and p70S6K, directly by phosphorylating Ser79 in ACC, and indirectly by inhibiting p70S6K phosphorylation, and (b) both activation and inhibition of protein phosphatases are involved in the activation of p70S6K by amino acids. p70S6K adds to an increasing list of targets of AMPK in agreement with the inhibition of energy-consuming biosynthetic pathways.
某些氨基酸,如谷氨酰胺和亮氨酸,可在肝脏中诱导合成代谢反应。它们分别激活参与蛋白质和脂肪酸合成的p70核糖体蛋白S6激酶(p70S6K)和乙酰辅酶A羧化酶(ACC)。相比之下,AMP激活的蛋白激酶(AMPK)可感知细胞的能量状态,并在代谢应激下被激活,它通过磷酸化生物合成途径中的关键酶使其失活,从而节省ATP。在本文中,我们研究了AMPK激活以及蛋白磷酸酶抑制剂对悬浮培养的肝细胞中氨基酸诱导的p70S6K和ACC激活的影响。AMPK在缺氧条件下或通过与5-氨基咪唑-4-甲酰胺核糖核苷(AICAr)或线粒体氧化磷酸化抑制剂寡霉素孵育而被激活。用氨基酸孵育肝细胞可通过多次磷酸化激活p70S6K。它还通过磷酸酶依赖性机制激活ACC,但不改变AMPK的激活状态。相反,当AMPK被激活时,氨基酸诱导的ACC和p70S6K激活被阻断或逆转。这种AMPK激活增加了ACC中Ser79的磷酸化,但降低了p70S6K中Thr389的磷酸化。在与氨基酸孵育前加入蛋白磷酸酶抑制剂可阻止p70S6K激活,而在与氨基酸预孵育后加入则增强p70S6K激活。得出的结论是:(a)AMPK直接通过磷酸化ACC中的Ser79并间接通过抑制p70S6K磷酸化来阻断氨基酸诱导的ACC和p70S6K激活;(b)蛋白磷酸酶的激活和抑制均参与氨基酸对p70S6K的激活。与抑制耗能生物合成途径一致,p70S6K加入了AMPK越来越多的靶标列表中。